Literature DB >> 36070302

Design and evaluation of an MRI-ready, self-propelled needle for prostate interventions.

Jette Bloemberg1, Fabian Trauzettel1, Bram Coolen2, Dimitra Dodou1, Paul Breedveld1.   

Abstract

Prostate cancer diagnosis and focal laser ablation treatment both require the insertion of a needle for biopsy and optical fibre positioning. Needle insertion in soft tissues may cause tissue motion and deformation, which can, in turn, result in tissue damage and needle positioning errors. In this study, we present a prototype system making use of a wasp-inspired (bioinspired) self-propelled needle, which is able to move forward with zero external push force, thereby avoiding large tissue motion and deformation. Additionally, the actuation system solely consists of 3D printed parts and is therefore safe to use inside a magnetic resonance imaging (MRI) system. The needle consists of six parallel 0.25-mm diameter Nitinol rods driven by the actuation system. In the prototype, the self-propelled motion is achieved by advancing one needle segment while retracting the others. The advancing needle segment has to overcome a cutting and friction force while the retracting needle segments experience a friction force in the opposite direction. The needle self-propels through the tissue when the friction force of the five retracting needle segments overcomes the sum of the friction and cutting forces of the advancing needle segment. We tested the performance of the prototype in ex vivo human prostate tissue inside a preclinical MRI system in terms of the slip ratio of the needle with respect to the prostate tissue. The results showed that the needle was visible in MR images and that the needle was able to self-propel through the tissue with a slip ratio in the range of 0.78-0.95. The prototype is a step toward self-propelled needles for MRI-guided transperineal laser ablation as a method to treat prostate cancer.

Entities:  

Mesh:

Year:  2022        PMID: 36070302      PMCID: PMC9451087          DOI: 10.1371/journal.pone.0274063

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


1. Introduction

1.1 Focal laser ablation

Prostate cancer is the second most common cancer diagnosed in men and the fifth leading cause of cancer-related deaths for men worldwide in 2020 [1]. When prostate cancer is diagnosed at an early stage, it can be treated locally using focal therapy that reduces the risk of side effects by preserving noncancerous tissue [2]. Focal laser ablation of the prostate is an appealing focal therapy option as it leads to homogeneous tissue necrosis caused by a laser fibre and does not appear to alter the sexual and urinary function of the patient [3]. Prostate cancer diagnosis and focal laser ablation require needle insertion to obtain core biopsies [4, 5] and position optical fibres near the target zone [6]. To this end, the clinician inserts the needle by pushing it through the tissue, which might lead to tissue strain in the needle vicinity [7], which in turn might cause functional damage to the surrounding tissues and organs [8], including the urethra, the rectum’s anterior wall, and the pelvic sidewall [9]. Moreover, tissue motion and deformation might lead to needle positioning errors and poor control of the needle path [10]. As a result, clinicians typically need multiple attempts to reach the target location, leading to an increased risk of tissue damage [7]. Moreover, pushing the needle through the tissue requires an axial force on the needle. When this axial force exceeds the needle’s critical load, the needle will deflect laterally—a phenomenon called buckling [11]. The lateral deflection might damage tissue in the needle vicinity and lead to poor control of the needle path [12, 13].

1.2 State-of-the-art in self-propelled needles

In an attempt to reduce tissue damage during needle insertion, needle designs have been developed that can be advanced without being pushed through the tissue. For instance, Ilami et al. [14] developed a needle with a magnetic tip that utilizes electromagnetic force and torque actuation to advance the needle through the tissue. Schwehr et al. [15] proposed a needle design that likewise utilizes electromagnetic torque to steer combined with a screw tip to allow the needle to pull itself through the tissue. A disadvantage of needle designs that utilize an electromagnetic field is that they are not compatible with magnetic resonance imaging (MRI). Besides electromagnetically actuated needles, wasp-inspired self-propelled needles have been developed [7, 16–18]. Female parasitic wasps pass their eggs through an ovipositor into their hosts, which sometimes hide in a solid substrate such as wood [19]. The tube-like ovipositor consists of three slender, parallel-positioned segments, called valves [20], which advance and retract with respect to each other in a reciprocating manner [20] (Fig 1A). A groove-and-tongue mechanism interlocks the valves along their length [21, 22]. The advancing-retracting motion of the valves has two functions. First, it keeps the unsupported length of the individual valves low [11]. Second, moving the individual valves forward one by one while retracting the others provides stability to the wasp’s ovipositor and prevents buckling [11, 23]. The advancement and retraction forces produce a net force near zero, enabling a self-propelled motion.
Fig 1

Visualisation of the motion sequence of the ovipositor of a parasitic wasp.

(A) The ovipositor consists of three parallel valves that can move reciprocally (based on Cerkvenik et al. [20]). (B) Schematic illustration of ovipositor-inspired needle insertion into tissue with one advancing needle segment (yellow) and two retracting needle segments (grey). Ffric, is the friction force along the advancing needle segment, Fcut, is the cutting force on the tip of the advancing needle segment, and Ffric, is the friction of the retracting needle segments, which works in the opposite direction as the friction force of the advancing needle segments.

Visualisation of the motion sequence of the ovipositor of a parasitic wasp.

(A) The ovipositor consists of three parallel valves that can move reciprocally (based on Cerkvenik et al. [20]). (B) Schematic illustration of ovipositor-inspired needle insertion into tissue with one advancing needle segment (yellow) and two retracting needle segments (grey). Ffric, is the friction force along the advancing needle segment, Fcut, is the cutting force on the tip of the advancing needle segment, and Ffric, is the friction of the retracting needle segments, which works in the opposite direction as the friction force of the advancing needle segments. Self-propelled needles do not require an external push force to advance through the tissue. They consist of multiple parallel segments that can slide along each other. The self-propelled motion is achieved by counterbalancing the cutting and friction force of the advancing segments by the friction force generated by other stationary or retracting segments [18]. For a self-propelled motion of the needle, Eq 1 holds: where p is the number of advancing needle segments, r is the number of retracting needle segments, and Ffric and Fcut are the friction and cutting force, respectively (Fig 1B). For the self-propelled motion to occur, the friction force of the retracting needle segments should overcome the sum of the friction and cutting forces of the advancing needle segments. In this way, the needle as a whole self-propels through the tissue by gradually moving the needle segments forward. Worldwide, a number of ovipositor-inspired needles have been developed so far. Oldfield et al. [24], Frasson et al. [25], and Leibinger et al. [7] showed that tissue motion and damage around a needle are reduced when using a multi-segmented needle actuated with a reciprocal advancing-retracting motion compared to pushing the needle as a whole through the tissue. Parittotokkaporn et al. [23] showed that probes with a directional friction pattern inspired by the wasp ovipositor, actuated with an advancing-retracting motion, could move tissue along the needle surface without applying an external push force to the tissue. Scali et al. [26, 27] replaced the complex-shaped interlocking groove-and-tongue mechanism of the wasp valves with Nitinol rods devoid of serrations and bundled by a shrinking tube, resulting in an ultrathin 0.4-mm diameter needle with six longitudinal segments [27]. Actuated by electric motors, the needle self-propels without buckling by advancing one needle segment at a time and slowly retracting the other five segments [26]. Furthermore, it is possible to steer the needle by inducing an offset between the needle segments, creating a discrete bevel-shaped tip [26].

1.3 Goal of this research

Wasp-inspired self-propelled needles could enable the clinician to reach the target tissue while avoiding unwanted tissue damage in and around the prostate. To guide needle positioning for focal laser ablation, MRI is an attractive imaging option because it provides visualisation of the target zone and real-time temperature monitoring [28, 29]. Current prototypes of wasp-inspired self-propelled needles use electric motors to actuate the individual needle segments [18, 25]. These needles cannot be used in MRI-guided procedures, as the electric motors interfere with the magnetic field. The aim of this research was, therefore, to design an MR-safe actuation system for a self-propelled needle and to evaluate its performance in human prostate tissue.

2. Design

2.1 Design requirements

The complete design, called Ovipositor MRI-Needle, consists of a needle and an actuation unit. Following the design of Scali et al. [27], we decided to focus our research on a self-propelled wasp-inspired needle consisting of six parallel needle segments with a central lumen. To reach the prostate transperineally [30], we opted for a needle length of 200 mm. To comply with conventional needles used for optical biopsy and optical treatment fibre positioning [6], we used a maximum needle diameter of 1 mm. To enable evaluation in a closed-bore preclinical 7-T MRI system (MR Solutions, Guildford, United Kingdom) with an inner diameter of the radiofrequency (RF) coil of 65 mm, we developed an actuation unit fitting within this coil, the actuation unit’s diameter not exceeding 65 mm, and the actuation unit containing a 2-mm diameter central hollow core to allow insertion of a functional element, such as an optical fibre. Finally, the materials used in the needle and the actuation unit are MRI-compatible to allow placing them inside the MRI system.

2.2 Overall system design

The needle’s self-propelled motion requires a sequential translation of the six needle segments in six steps per cycle. During every step of the motion, one needle segment moves forward over a specified distance called the “stroke,” while the other five needle segments move slowly backwards over one-fifth of the stroke distance (Fig 2A). The needle segments are continuously in motion in order to apply a constant strain to the surrounding tissue. We opted for a manually-controlled actuation system that allows the operator to drive the needle in simple discrete actuation steps, avoiding the need to set the exact advancing or retracting distance for each needle segment during each actuation step. Fig 2B shows how the operator drives the actuation unit by a stepwise manual translation of a translation ring (in red). The actuation unit converts the reciprocating motion of the translation ring into a global rotating motion of an internal selector, after which the selector selects and actuates the needle segments in the required order and over the required distance.
Fig 2

Visualisation of the motion sequence of the needle segments.

(A) During the motion, one needle segment moves forward over the stroke distance while the other needle segments move slowly backwards over one-fifth of the stroke distance in a consecutive manner. (B) Manual translation of a translation ring (red) drives the actuation system. The actuation system converts the reciprocating motion of the translation ring into a sequential translation of the six needle segments.

Visualisation of the motion sequence of the needle segments.

(A) During the motion, one needle segment moves forward over the stroke distance while the other needle segments move slowly backwards over one-fifth of the stroke distance in a consecutive manner. (B) Manual translation of a translation ring (red) drives the actuation system. The actuation system converts the reciprocating motion of the translation ring into a sequential translation of the six needle segments.

Selector

The design of the selector is based on the so-called click-pen mechanism of a ballpoint pen, Fig 3 [31]. The click-pen-mechanism converts the discrete motion of pressing the button at the end of the pen into a rotation and a subsequent translation of the ballpoint tip. Fig 4 shows the working principle of our selector (in green). The cylindrical mechanism is simplified and visualised in a two-dimensional (2D) schematic illustration to explain the working principle. The columns in Fig 4 show the subsequent steps in the motion cycle. The rows in Fig 4 show the different layers of the selector. The selector (Fig 4A–4D) contains two sets of aligned teeth. A fixed housing (in grey) also contains two sets of teeth. For the housing, the teeth at the right are shifted over half a tooth width. The selector is actuated by the input motion: a reciprocating translating motion in the horizontal x-direction. When the operator moves the selector in the positive x-direction (Fig 4A), the teeth on the right side of the selector come in contact with the teeth on the right side of the housing (Fig 4B, the interacting teeth of the housing are indicated in dark grey). The interaction between the teeth causes the selector to move in the negative y-direction over half the pitch distance of the teeth until the selector motion is blocked by the teeth so that it cannot move any further. In the following step, the selector is moved in the negative x-direction (Fig 4C) until the selector’s left teeth come in contact with the housing’s left teeth (Fig 4D), causing the selector to move again in the negative y-direction over half the teeth’ pitch distance until the motion is again blocked. The interaction between the teeth of the selector and the housing converts the reciprocating horizontal motion that actuates the selector into a stepwise vertical translation.
Fig 3

Click-pen mechanism of a ballpoint pen.

Illustration of one of the first patented click-pen mechanisms (Parker Pen Co Ltd) [31].

Fig 4

Schematic representation of the selector motion mechanism in 2D, including the selector (green), housing (grey), cam (orange), and needle segment holders (yellow).

The columns show the subsequent steps in the motion cycle. The rows show the different layers of the selector.

Click-pen mechanism of a ballpoint pen.

Illustration of one of the first patented click-pen mechanisms (Parker Pen Co Ltd) [31].

Schematic representation of the selector motion mechanism in 2D, including the selector (green), housing (grey), cam (orange), and needle segment holders (yellow).

The columns show the subsequent steps in the motion cycle. The rows show the different layers of the selector.

Cam

Fig 4E–4H show how the selector contains small protruding cylinders (in dark green) that can slide in straight horizontal slots in a cam (in orange). The housing prevents the cam from translating in the horizontal x-direction. When the selector is translated in the positive or negative x-direction, the protruding cylinders transmit the selector’s stepwise translation in the y-direction to the cam. Fig 4I–4L show that the cam contains a V-shaped slot (in light orange). Six needle segment holders (Fig 4I–4L, in yellow) contain small protruding cylinders (in light yellow) that can slide in the cam’s V-shaped slot. The housing restricts the motion of the needle segment holders to a translation in the x-direction driven by the motion of the V-shaped slot. The asymmetric shape of the V causes one needle segment holder to move in the positive x-direction, with the other needle segment holders moving slowly in the negative x-direction.

Working principle in 3D

The stepwise translation of the selector in the y-direction in the simplified 2D illustration in Fig 4 is, in reality, a stepwise rotation around the x-axis in 3D. Fig 5 shows the 3D working principle of the selector (in green), surrounded by a concentric housing (in grey) and driving the six needle segment holders (in yellow) via the cam (in orange). The inside of the mechanism contains a hollow core to introduce additional instrumentation. The housing and the selector both contain six teeth on the left and right sides. Therefore, the selector’s translation in the positive or negative x-direction results in a 30° rotation around its x-axis as the selector slides over half the pitch distance of the teeth.
Fig 5

Schematic motion sequence of the selector in 3D, including the selector (green), housing (grey), cam (orange), and needle segment holders (yellow).

We designed the actuation unit using Solidworks (Dassault Systems Solidworks Corporation; Waltham, MA, USA). To facilitate the manual actuation of the selector, we added a translation ring to the actuation unit (Fig 6, Part 4 in red). The operator drives the translation ring with a reciprocating translating motion. Cylindrical pins on the translation ring interact with a circumferential slot in the selector, transmitting the translating motion in the x-direction while allowing the selector to rotate without the need for the operator’s hand to rotate.
Fig 6

Exploded view (A) and cross-section (B) of the actuation unit of the Ovipositor MRI-Needle, consisting of a housing bottom (1), cam bottom (2), cam top (3), translation ring (4), selector (5), needle segment holder (6), housing top (7), lock ring (8), inner double cone (9), and outer double cone (10).

The needle segments run through the actuation unit at a larger diameter than at the needle tip. In order to guide the needle segments smoothly from the actuation unit to the needle tip, a double cone (blue) was designed at the distal side of the actuation unit. The double cone gently decreases the distance between the needle segments by guiding them smoothly through S-shaped channels from the actuation unit to the needle tip. These channels allow the needle segments to move back and forth freely while avoiding buckling.

2.3 Prototype manufacturing

Material selection

The American Society for Testing and Materials (ASTM) F2503 standard distinguishes three classifications for medical devices in the MR environment: MR-safe, MR-conditional, and MR-unsafe [32]. MR-safe devices are composed of electrically non-conductive, non-metallic, and non-magnetic materials; these devices are inherently safe to use in an MR environment [32]. Additionally, MR compatibility indicates the usability of the device in an MR environment, including potential image quality issues introduced by the device, according to ASTM F2119 [33].

Needle

For use inside an MRI system, the Ovipositor MRI-Needle must be at least MR conditional and MR compatible. Nitinol is metallic and, therefore, MR conditional at best. Nitinol is paramagnetic, meaning an external magnetic field weakly magnetises it while it loses its magnetism when the external magnetic field is removed [34]. Nitinol has a lower magnetic susceptibility than stainless steel; hence it produces fewer image artefacts than stainless steel [35, 36]. Therefore, medical devices made from Nitinol are frequently used in MRI-guided clinical procedures [37, 38]. The susceptibility difference between a Nitinol needle and the surrounding tissue may give rise to signal voids (due to strong T2* related signal decay) in the vicinity of the needle, which can be exploited as visualisation of the Nitinol needle [38, 39]. To comply with the diameter of conventional optical biopsy needles and optical treatment fibre positioning, the needle in this study consists of six 0.25-mm diameter rods, i.e., the needle segments. The needle segments are superelastic straight annealed Nitinol rods with a diameter of 0.25 mm and a length of 276 mm, of which we placed 76 mm inside the actuation unit and 200 mm outside. The needle length is 200 mm to reach the prostate transperineally [30]. We glued the Nitinol rods (Pattex instant glue, Gold Gel) inside the needle segment holders (Fig 7). The cyanoacrylate-based glue is inherently biocompatible [40]. Fig 7A shows the tips of the needle segments, sharpened to an angle of 40° with wire electrical discharge machining. A 10-mm long shrinking tube (Vention Medical, expanded inner diameter 0.814 mm, wall thickness 0.013 mm) holds the six Nitinol rods together at the tip to limit the diverging of the needle segments while only minimally increasing the needle diameter. The shrinking tube is glued (Pattex instant glue, Gold Gel) to one of the needle segments to maintain its position at the needle tip. The remaining needle segments can move freely back and forth through the shrinking tube while the needle segments are bundled at the tip. The resulting diameter of the needle, including the shrinking tube, is 0.84 mm.
Fig 7

Ovipositor MRI-Needle (A) Close-up of the needle tip consisting of six sharpened Nitinol rods held together by a shrinking tube (Vention Medical) glued to one of the six rods. (B) Assembled prototype. The grey parts, i.e., the housing components, were produced using fused deposition technology (FDM) in polylactic acid (PLA) on an Ultimaker 3 printer. The orange parts, i.e., the actuation unit’s internal components and the inner and outer double cones, were produced using stereolithography (SLA) technology in Dental Model resin V2 (Formlabs) on a Formlabs Form 3B printer. A transparent polymethyl methacrylate (PMMA) support structure supports the prototype, and a white polylactic acid (PLA) guide tube supports the needle in the support structure.

Ovipositor MRI-Needle (A) Close-up of the needle tip consisting of six sharpened Nitinol rods held together by a shrinking tube (Vention Medical) glued to one of the six rods. (B) Assembled prototype. The grey parts, i.e., the housing components, were produced using fused deposition technology (FDM) in polylactic acid (PLA) on an Ultimaker 3 printer. The orange parts, i.e., the actuation unit’s internal components and the inner and outer double cones, were produced using stereolithography (SLA) technology in Dental Model resin V2 (Formlabs) on a Formlabs Form 3B printer. A transparent polymethyl methacrylate (PMMA) support structure supports the prototype, and a white polylactic acid (PLA) guide tube supports the needle in the support structure.

Actuation unit

We used three-dimensional (3D) printing for the production of the actuation unit. The double cone of the actuation unit consists of two parts, an inner and an outer part, containing external and internal semi-circular grooves, respectively. We composed the double cone out of two parts with semi-circular grooves rather than one part with circular channels to prevent closing off those channels while using the stereolithography (SLA) 3D-printing process. Fig 6A shows that the double cone’s outer part contains a hive structure. The hive structure leads to short grooves and short horizontal bridges across the grooves. A bridge is a material that links two raised points. Long bridges are likely to fail during the 3D-printing process or break during the post-processing of the 3D-printed component, thus closing off the needle grooves. The hive structure facilitates the 3D-printing process by creating short bridges that will not fail [41]. Fig 7B shows the 3D-printed components of the actuation unit as well as the assembled prototype. The components of the actuation unit were 3D printed on two different 3D printers, an SLA printer and a fused deposition modelling (FDM) printer. Two printers with different print settings with respect to the layer height were used to allow for a smooth gliding motion of the selector inside the housing. If the selector and housing were printed with the same layer height, they would fit together like puzzle pieces, leading to jamming of the selector inside the housing. The components of the actuation unit were 3D printed with Formlabs and Ultimaker 3D printers, using Dental Model V2 resin (Formlabs) and polylactic acid (PLA), respectively, both materials being MR safe. We printed the SLA parts using a Formlabs Form 3B printer with a layer height of 0.050 mm, and the FDM parts using an Ultimaker 3 printer with a layer height of 0.1 mm. During assembly, we glued the housing bottom and housing top together (Pattex instant glue, Gold Gel). The height of the cam track dictates a 4-mm stroke in the positive x-direction for the needle segment holders over a 60° rotation of the cam. During the following 300° rotation, the cam track dictates in steps a total of 4-mm stroke in the negative x-direction. The actuation unit’s length is 163 mm (Fig 6B), the outer diameter is 35 mm, and the outer diameter of the translation ring is 45 mm. The hollow core has a diameter of 2 mm.

3. Evaluation

3.1 Goal of the experiment

In a proof-of-principle experiment, the functioning of the developed Ovipositor MRI-Needle was evaluated in ex vivo human prostate tissue inside a preclinical 7-T MRI system (MR Solutions, Guildford, United Kingdom) at the Amsterdam University Medical Center (AUMC, department of Biomedical Engineering and Physics). The discarded human prostate sample was collected anonymously at the Amsterdam University Medical Center (www.amsterdamumc.org). The human prostate sample came from a deceased patient who had approved to donate his body to science, and his prostate was collected after autopsy. Therefore, this experiment was not subject to the Medical Research Involving Human Subjects Act (WMO), and it did not have to undergo review by an accredited Medical Research Ethics Committee or the Central Committee on Research Involving Humans. We evaluated the performance of the Ovipositor MRI-Needle in terms of the slip of the needle with respect to the prostate tissue. More specifically, we calculated the slip ratio over an entire measurement as in Eq 2: where dm and de are the measured and expected travelled distance, respectively. The expected travelled distance is 4 mm in one cycle due to the 4-mm stroke dictated by the cam track. In one cycle, all six needle segments are advanced in one step and retracted in five steps, meaning that one cycle equals a full rotation of the cam. For one cycle, we had to translate the translation ring for 12 repetitions. During one measurement, the needle was actuated for ten cycles, i.e., 120 translations of the translation ring, which means that the total expected travelled distance during one cycle was equal to 40 mm. The measured travelled distance is the difference in the position of the needle tip we measured in the MR images before and after the needle actuation for ten cycles.

3.2 Experimental setup

Fig 8 shows the experimental setup, consisting of the Ovipositor MRI-Needle, an ex vivo human prostate tissue sample embedded in agar in a tissue box, and a preclinical 7-T MRI system (MR Solutions, Guildford, United Kingdom). Instead of moving a needle towards the tissue, we decided to move the tissue in the tissue box towards the needle. Specifically, we kept the actuation unit stationary, fixed to the MRI system, to use the manual actuation force solely for the translation of the needle segments with zero external push force. The principle of needle insertion with zero external push force holds if the self-propelled needle pulls the tissue towards itself by pulling itself deeper into the tissue, thereby pulling the tissue box towards the needle. The MRI system contained a half-round tube that could be slid into and out of the housing of the MRI system. On top of the half-round tube, a radio frequency (RF) coil was positioned. Inside the RF coil, the tissue sample can be positioned to allow for visualisation using MRI acquisitions. During the performance evaluation of the Ovipositor MRI-Needle, we were interested in the position of the needle tip; therefore, the tissue box was placed inside the RF coil. The RF coil has an inner radius of 65 mm. In order to test the Ovipositor MRI-Needle inside the MRI system, we needed a movable support structure for the tissue box to allow low-friction horizontal translation of the tissue box inside the RF coil while constraining the rolling motion in the lateral direction. The low-friction structure consisted of box rails attached to the tissue box, an RF base plate attached to the RF coil, and wheels between the box rails and RF base plate; for more details, see S1 Appendix.
Fig 8

Experimental setup of the ex vivo prostate tissue experiment.

(A) The instrument was placed in a half-round tube with a support structure in between. The half-round tube was slid into the MRI bore. (B) Close-up of the radiofrequency (RF) coil with the tissue box on the RF base plate, guided on rails. (C) Close-up of the proximal side of the tissue box containing seventeen insertion holes. (D) Close-up of the ex vivo prostate tissue embedded in solidified 2.5%wt agar, with the needle inserted through the agar in front of the tissue.

Experimental setup of the ex vivo prostate tissue experiment.

(A) The instrument was placed in a half-round tube with a support structure in between. The half-round tube was slid into the MRI bore. (B) Close-up of the radiofrequency (RF) coil with the tissue box on the RF base plate, guided on rails. (C) Close-up of the proximal side of the tissue box containing seventeen insertion holes. (D) Close-up of the ex vivo prostate tissue embedded in solidified 2.5%wt agar, with the needle inserted through the agar in front of the tissue. We prepared the biological sample by placing a piece of ex vivo human prostate tissue (width 25 mm, length 50 mm, height 10 mm) in a preparation box with liquid agar (2.5%wt). Storing the box in the refrigerator overnight, fixated the tissue in the agar. We cut the sample to the correct dimensions (width 50 mm, length 90 mm, height 10 mm, weight 52 g) to fit inside the tissue box used in the experiment, with the prostate tissue at the tissue’s box distal end aligned with a central hole in the wall of the box for insertion of the needle. The remaining part of the tissue box filled with agar allowed an initial insertion depth of 40 mm of the needle into the agar before entering the prostate tissue. To enable multiple slip ratio measurements in a single prostate tissue sample, the box contained multiple holes for insertion of the needle, allowing testing in different parts of the prostate sample with a new needle trajectory for each measurement. The insertion holes were placed at a distance of 2.5 mm from each other to avoid overlapping needle trajectories, resulting in a total of seventeen holes numbered from one to seventeen from left to right (Fig 8C). We positioned the needle in front of the tissue so it could move through the tissue. Unfortunately, because of tissue inhomogeneities or the absence of tissue behind the holes, experiments could only be carried out in a few specific holes (no. 6, 7, and 9). The tissue behind these specific holes appears homogenous on the MR images. Hence, we assumed the behaviour of the needle to be the same for the experiments using these holes.

3.3 Experimental procedure

In our experiment, we used 3D gradient-echo acquisitions to capture the needle position with respect to the prostate tissue and the tissue box (see S2 Appendix for imaging parameters). We conducted three measurements using three different insertion holes in a randomised order. During a single measurement, the Ovipositor MRI-Needle was actuated for ten actuation cycles, i.e., 120 translations of the translation ring. For every measurement, a 3D gradient echo acquisition captured the static needle position at the start and after the ten actuation cycles. S3 Appendix contains a detailed explanation of the steps in the experimental protocol. After each measurement, we cleaned the needle with water and alcohol. All measurements were conducted in one day.

3.4 Experimental results

3D gradient-echo acquisitions visualised the start and end position of the needle tip. Fig 9 shows the MR images of the needle tip positions (Original MR images can be found in S4 Appendix). Table 1 shows the insertion depth and travelled distance measurements. The initial insertion depth was that of the needle tip when it was positioned in front of the prostate tissue. The travelled distance was the distance the needle travelled inside the prostate tissue. The needle was able to propel itself through the prostate tissue. However, the needle did experience slip. We measured a slip ratio in the range of 0.78–0.95. This slip indicates that the needle segments unintentionally slide with respect to the tissue, resulting in a shorter measured travelled distance than the expected travelled distance.
Fig 9

MR images of the needle inside the agar and ex vivo prostate tissue.

Each row represents one measurement. The first column shows the initial frame where the tip is positioned inside the agar in front of the prostate tissue. The second column shows the frame after actuation over five cycles. The third column shows the frame after the second actuation over five cycles. The yellow, red, and green contours show the needle, the prostate tissue, and the tissue box sides, respectively. The arrow marks the needle tip. The orange crosshair shows the reference point on the side of the box that indicates a 40-mm insertion depth. The number in the upper right corner in black shows the measured travelled distance of the tissue box, dm, in mm, with respect to the previous MR image.

Table 1

Results of the ex vivo evaluation.

MeasurementInsertion holeInitial insertion depth [mm]Measured travelled distance, dm [mm]CyclesExpected travelled distance, de [mm]Slip ratio, sratio
1944.18.810400.78
2650.92.310400.94
3751.91.910400.95

For each measurement, the following information is reported: the insertion hole used on the tissue box, measured travelled distance [mm] of the box, number of cycles needed to travel that distance, expected travelled distance [mm] that the box would have travelled if no slip occurred, and the slip ratio.

MR images of the needle inside the agar and ex vivo prostate tissue.

Each row represents one measurement. The first column shows the initial frame where the tip is positioned inside the agar in front of the prostate tissue. The second column shows the frame after actuation over five cycles. The third column shows the frame after the second actuation over five cycles. The yellow, red, and green contours show the needle, the prostate tissue, and the tissue box sides, respectively. The arrow marks the needle tip. The orange crosshair shows the reference point on the side of the box that indicates a 40-mm insertion depth. The number in the upper right corner in black shows the measured travelled distance of the tissue box, dm, in mm, with respect to the previous MR image. For each measurement, the following information is reported: the insertion hole used on the tissue box, measured travelled distance [mm] of the box, number of cycles needed to travel that distance, expected travelled distance [mm] that the box would have travelled if no slip occurred, and the slip ratio.

4. Discussion

4.1 Needle performance

This study reported on the design and experimental validation of a self-propelled needle with an MRI-ready actuation system. The evaluation of the needle in ex vivo prostate tissue showed the needle was able to advance through the tissue. However, the needle did experience a high slip ratio. We measured a slip ratio in the range of 0.78–0.95. The slip ratio of our needle in ex vivo prostate tissue is comparable to that of the self-propelled needle developed by Scali [18], who reported a slip ratio in the range of 0.87–0.90 for the continuously moving needle in ex vivo porcine liver tissue. The high slip ratio in our measurements indicates that the cutting and friction forces acting on the advancing needle segment and the friction forces on the wheels of the support structure altogether were near the friction forces on the retracting needle segments (Eq 1). Furthermore, despite the shrinking tube, the needle segments diverged a little at their tips like an opening umbrella during the experiment, hindering the needle segments’ advancing motions, thereby increasing the needle’s slip ratio. The degree to which the segments diverged at the needle tip could not be quantified because of the low resolution of the MRI system used.

4.2 Limitations

The needle segments were designed and sharpened so that the needle segments point toward the middle of the needle. However, the needle segments did not always point toward the middle of the assembled prototype. This could be explained by the way the needle segments are bundled. Along the length of the 200-mm needle, the needle segments were only connected at the tip by a 10-mm long shrinking tube. Hence, the needle segments could change position during the experiment, causing the needle segments to rotate and entangle. Because the needle segments did not point toward the middle, their bevel-shaped tips might have caused them to diverge and allow tissue accumulation between them. In future designs, we aim to point all bevel-shaped tips toward the middle of the needle tip by restricting their rotation to prevent the needle segments from diverging. At the needle tip, the six needle segments are surrounded by the shrinking tube, which might hinder the needle’s self-propelling motion through the tissue. However, as the needle is advanced further into the tissue, the surface area of the needle segments in direct contact with the tissue increases, whereas the surface area of the shrinking tube in contact with the tissue remains unchanged. Consequently, the influence of the shrinking tube on the self-propelling motion declines as the needle advances further into the tissue. In a future version of the Ovipositor MRI-Needle, we will investigate methods to replace the shrinking tube with another connection mechanism to improve the needle’s self-propelling motion.

4.3 Future work

In this study, we placed the tissue in a box that moved towards the needle. For application in transperineal laser ablation, the needle will have to self-propel through the perineal skin and into the prostate while the patient stays still inside the MRI bore. The actuation unit can be placed on a robotic arm suited to move the needle towards the cancerous tissue. The current Ovipositor MRI-Needle uses a discrete manual translating motion of the translation ring as its input. In future work, the translation ring could be replaced with a motorised actuation unit that is safe for use in an MRI environment. Electric motors are not an option due to the interference of these motors with the magnetic field. Alternative actuation methods are piezo motors, ultrasonic motors, Bowden cables, pneumatics, hydraulics, magnetic spheres, and shape memory alloy actuators. In a hospital setup, pneumatics are advantageous as pressurised air is commonly available in an MRI room. An important drawback of pneumatics is that air is compressible, so the only well-defined pneumatic actuator positions are the beginning and end positions [42]. This makes pneumatic actuators more suited for a discrete stepwise motion instead of continuous motion. Our selector mechanism is currently actuated by a stepwise manual translation, which can relatively easily be replaced by a stepwise pneumatic actuation mechanism. In our experiment, the performance evaluation of the Ovipositor MRI-Needle was limited to an evaluation in a single ex vivo frozen-thawed prostate sample embedded in agar. Larger sample sizes are needed for future evaluations, considering that the mechanical properties of the prostate tissue of different men are not the same but comprise ranges of values. Another limitation was that the sample was frozen quickly at -80 ºC in liquid nitrogen and thawed prior to the experiment. While rapid freezing reduces ice crystal formation in the tissue and minimizes morphological changes [43], Venkatasubramanian et al. [44] demonstrated that freezing tissue in liquid nitrogen could affect tissue stiffness compared to fresh tissue, with the exact effects of this freeze-thaw cycle on the mechanical properties of the tissue being still unknown. However, this effect might not influence the needle’s self-propelling motion as in our experiment, the Ovipositor MRI-Needle could self-propel through tissue that had been frozen. In comparison, Scali [18] evaluated the performance of a wasp-inspired self-propelled needle in ex vivo four hours post mortem porcine tissue that did not undergo a freeze-thaw cycle and showed that the needle could self-propel through relatively fresh ex vivo tissue with a comparable slip ratio as the Ovipositor MRI-Needle in ex vivo prostate tissue. Another limitation related to our experiment conditions, the agar (2.5%wt) in which the prostate tissue was embedded was stiffer than the prostate tissue itself, which could have affected the self-propelling motion of our Ovipositor MRI-Needle. Scali et al. [27] showed that the slip ratio of a self-propelled needle was higher in tissue stiffer compared to less stiff phantoms. This indicates that the stiff agar in our experiment could have increased the slip ratio of the Ovipositor MRI-Needle compared to when the needle would advance through prostate tissue. In future studies, in vivo experiments are needed to test the performance of the needle in a more realistic clinical scenario. When moving toward an in vivo study, we foresee some challenges, such as the imaging system, the presence of blood flow through the prostate gland, and the presence of multi-layered tissue. For in vivo tests inside porcine animal models, we need an MRI system with a bore and RF coil that fits the animal model, as the currently used preclinical MRI system has an RF coil diameter of only 65 mm. Alternatively, other imaging options like ultrasound could be used, which will have their own advantages and disadvantages, such as low contrast for soft tissues [45]. The presence of blood flow could decrease the needle-tissue friction required for the self-propelling motion. However, the parasitic wasp is able to advance through more liquid substrates such as fruits (e.g., figs) [46, 47] thanks to harpoon-like serrations on the valves, which increase friction [47]. Similarly, a microtextured directional surface topography could be added to the needle surface, as shown by Parittotokkaporn et al. [48]. Another challenge is that in an in vivo model, there is more and multi-layered tissue between the insertion point (i.e., the perineum) and the target position inside the prostate gland. However, other self-propelled needles have been shown to be able to advance in multi-layered tissue-mimicking phantoms consisting of gelatine with different stiffnesses [27]. Moreover, when the needle is inserted through multiple layers of tissue and thus deeper into the tissue, the self-propelling motion is expected to work better, as the role of the cutting force of the single advanced segment becomes less pertinent compared to the friction forces of the retracted segments. In this study, we kept the actuation unit stationary while the box was placed on a low-friction support structure that moved towards the needle. In clinical practice, the needle will have to self-propel inside the patient while the tissue remains in place. The actuation unit could be placed on a dedicated robotic arm to manipulate the needle towards the patient, following the pace of the self-propelling motion of the needle. Moreover, for the future production of the needle segments, industrial needle manufacturing processes could be used to produce a needle with a sharper tip (e.g., a lancet point) to facilitate the propulsion through the tissue. Currently, clinicians typically need multiple attempts to reach the target location, leading to an increased risk of tissue damage [7]. Moreover, a narrow pubic arch or a large prostate can obstruct the needle trajectory, making it difficult to reach certain prostate locations [49]. Steerable needles can help the clinician compensate for positioning errors and follow a curved path to reach all positions inside the prostate while avoiding anatomical obstacles. In a future version of the Ovipositor MRI-Needle, a steering mechanism can be incorporated. Steering can be achieved by creating an offset between the needle segment tips to approximate a bevel-shaped tip. The surrounding tissue exerts forces on the bevel-shaped tip in an asymmetric fashion, resulting in the bending of the needle in the direction of the bevel [50]. Research by Scali et al. [26] on wasp-inspired steerable needles showed that approximated bevel-shaped tips could be used to steer the needle successfully. Research into steering will be incorporated in future prototypes of our needle. Considering the needle’s primary goal, its use in MRI-guided transperineal optical biopsy and focal laser ablation, the MR safety and compatibility of the components of the Ovipositor MRI-Needle should in the future be addressed using the ASTM test methods [32]. Radiofrequency heating caused by the Nitinol needle should be evaluated experimentally, as the Nitinol needle is a long and electrically conductive structure that couples with the electric field of the RF coil in an MRI system [51]. The coupling induces high voltages at the end of the needle, which might cause heating of the surrounding tissue that poses a potential safety hazard to the patient [51, 52]. Alternatively, the Nitinol needle segments could be replaced by needle segments made of electrically non-conductive, non-metallic, and non-magnetic materials such as polymer needle segments or glass fibres. An MRI-ready, self-propelled, steerable needle can serve as a platform technology for the precise positioning of a functional element in a target region in the body.

5. Conclusion

This work presents the design and experimental validation of a self-propelled needle with an MRI-ready actuation system. We have shown that a discrete manual translating motion can actuate the reciprocating motion of the six parallel needle segments using a selector. A continuous hollow core through the actuation unit allows for needle functionalisation with an optical fibre for optical biopsy and focal laser ablation. The prototype’s components, excluding the needle, are easily manufactured solely by 3D printing using MR-safe materials. The needle consists of six sharpened Nitinol rods. It was possible to determine the needle tip’s position in the MR image, as the Nitinol needle did not cause severe image artefacts. The evaluation of the prototype in ex vivo human prostate tissue in an MRI system showed that the needle was able to self-propel through the tissue. However, it experiences a high slip ratio. The Ovipositor MRI-Needle is a step forward in developing a self-propelled needle for MRI-guided transperineal focal laser ablation to treat prostate cancer.

Support structure design and manufacturing.

(DOCX) Click here for additional data file.

Magnetic resonance parameters.

(DOCX) Click here for additional data file.

Experimental protocol.

(DOCX) Click here for additional data file.

Study data and original MR images.

(DOCX) Click here for additional data file.

Video of the needle tip moving the needle segments subsequently.

(MP4) Click here for additional data file. 6 Jul 2022
PONE-D-22-12859
Design and evaluation of an MRI-ready, self-propelled needle for prostate interventions
PLOS ONE Dear Dr. Bloemberg, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Specifically, the authors should add more details related to the actuation method chosen and foreseen challenges in moving towards in-vivo characterizations. Please submit your revised manuscript by Aug 20 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Tommaso Ranzani, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. "Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors present an ingenious bio-inspired needle with six segments. It can be manually actuated by a cam mechanism that advances one of of the segments at a time. The design is interesting and definitely worth pursuing. The presentation is clear and the paper is well written. The major limitation of the design is the lack of experimentation in vivo. The problem is that needle channels in living tissue are almost instantaneously lubricated with blood and further tissue damage is also accompanied by inflammation. This may pose difficulties for the approach, as the needle track risks becoming very slippery. The ex vivo prostate study is helpful but it does not present the full potential issue. To check this, the authors do not need to carry out the experiment in MRI; they could instead use ultrasound and an animal study at the local hospital. Porcine models are used all the time for teaching, so it will not be a huge effort to quantify performance of their device in living animal tissue, e.g. a porcine liver. I would like to see some discussion of this observation in the paper and plans to address the potential problem of friction (or lack thereof). Reviewer #2: In this work the authors present a design for a self-inserting needle with potential applications in prostate biopsy/ablation. The study experimentally evaluates the ability of the needle to insert itself, quantitatively measuring the slip ratio during deployment. The study was conducted in cadaveric human prostate tissue embedded in an agar gel phantom. The paper is very well-written and clearly presents the design, evaluation study, and results. The reviewer has a few comments and suggestions for improvement. In no particular order: There have also been recent works in other types of needles that are pulled from their tip rather than pushed from their base. For instance, [1] leverages magnetic force to pull the needle, and recently [2] leverages a screw-tip mechanism to pull the needle and magnetic torque to steer the needle. The authors may consider mentioning designs such as these which, while significantly different, may exhibit similar benefits as the proposed design: [1] M. Ilami, R. J. Ahmed, A. Petras, B. Beigzadeh, and H. Marvi, “Magnetic Needle Steering in Soft Phantom Tissue”, Scientific Reports, 10(1), pp. 1-11, 2020. [2] T. J. Schwehr, A. J. Sperry, J. D. Rolston, M. D. Alexander, J. J. Abbott, and A. Kuntz, "Toward Targeted Therapy in the Brain by Leveraging Screw-Tip Soft Magnetically Steerable Needles", Hamlyn Symposium on Medical Robotics, pp. 81-82, 2022. In Equation 2, d_m and d_e are used, however when describing the equation, the authors define d_t (line 280). This discrepancy should be resolved. Do the authors have any intuition regarding the differences between the agar used in the study to surround the ex vivo prostate tissue and the tissue in the human body that would represent intermediate tissue the needle must move through en route to the prostate? It may be worth briefly discussing this point and its implications for the study/results. E.g., is it possible the agar may have exaggerated the slip in this case compared with human tissue? How does the shrinking tube that keeps the individual needle segments together near the tip impact the working principle of the self-propelled insertion? Does the shrinking tube hinder the insertion of the needle? If it affects this, to what expected degree? It may be worth discussing this point as well. Can the authors quantify the degree to which the needles diverged at their tips during the experiments? Doing so would add significant context to the observation. In lines 395-396 in the discussion section, the authors state “This makes pneumatic actuators more suited for a discrete, stepwise motion instead of a continuous motion by using our selector mechanism, for example.” This is unclear. Are the authors stating that their mechanism is an example of a continuous motion that does not suit itself to pneumatic actuators or are they instead stating the proposed mechanism is an example of a discrete motion? The text is ambiguous. However, it is my impression that the proposed needle would be an example that can well be actuated by stepwise pneumatic mechanisms. The authors mention the concern of heating of the nitinol in the MRI. It seems to me, however, that nitinol is not necessary as the material for the needle bundle. If the design could instead, theoretically, incorporate non-magnetic materials in the needle bundle, it may be worth mentioning this in the future work section when bringing up the heating concern. It may be an artifact of the review process, or fixed later in the editorial process, but it is worth noting that many of the figures exhibit quite low resolution. A few typos noted: Line 109 prostat…e Line 214 or visualization The paper is clearly presented and quite well written. If the above comments were addressed the paper would be further strengthened. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
26 Jul 2022 Dear Tommaso Ranzani, Thank you for contacting the reviewers. We have revised the manuscript accordingly. This letter was also uploaded as an attachment. Regarding the points as described in your email, we confirm that (1) we adapted the manuscript to meet PLOS ONE’s style requirements, (2) we provided the correct grant numbers for our study in the ‘Funding Information’ section in the submission system and we added an updated financial disclosure statement in our cover letter, (3) we uploaded our study’s minimal underlying data as Supporting Information file 4 (i.e., S4 Appendix. Study data and original MR images), (4) our ethics statement only appears in Section 3, and (5) we reviewed our reference list to make sure that it is complete and correct. Regarding the details related to the actuation method chosen and foreseen challenges in moving towards in vivo testing, we added a clarification in Section 4.3. In the first paragraph of Section 4.3, we explain that the manual actuation of the selector mechanism of the Ovipositor MRI-needle could be replaced by a stepwise pneumatic actuation mechanism (see also R7). We also added two paragraphs in Section 4.3 about the foreseen challenges for executing in vivo testing and the required improvements to the Ovipositor MRI-Needle before such testing becomes possible (see also R1). Please find our detailed responses to the reviewers below. In the revised manuscript, the changes are highlighted. Review Comments to the Author Reviewer #1: The authors present an ingenious bio-inspired needle with six segments. It can be manually actuated by a cam mechanism that advances one of of the segments at a time. The design is interesting and definitely worth pursuing. The presentation is clear and the paper is well written. The major limitation of the design is the lack of experimentation in vivo. The problem is that needle channels in living tissue are almost instantaneously lubricated with blood and further tissue damage is also accompanied by inflammation. This may pose difficulties for the approach, as the needle track risks becoming very slippery. The ex vivo prostate study is helpful but it does not present the full potential issue. To check this, the authors do not need to carry out the experiment in MRI; they could instead use ultrasound and an animal study at the local hospital. Porcine models are used all the time for teaching, so it will not be a huge effort to quantify performance of their device in living animal tissue, e.g. a porcine liver. I would like to see some discussion of this observation in the paper and plans to address the potential problem of friction (or lack thereof). R1. Thank you for your compliments. In Subsection 4.3, we now discuss the foreseen challenges in moving towards in vivo testing and the required adaptations to the prototype and experimental setup before such testing becomes possible. The following challenges regarding the tissue are mentioned: (1) the blood flow through the prostate gland and (2) more and multi-layered tissue between the insertion point (i.e., the perineum) and the target location inside the prostate. Regarding the experimental setup we discuss the MRI scanner that should fit the in vivo animal model. We discuss the following additional developments required for the Ovipositor MRI-Needle: (1) a robotic arm to move the needle towards the tissue instead of the tissue towards the needle and (2) further sharpening of the needle segments. Furthermore, we also discuss the potential problem of friction, how the parasitic wasp solves this problem and how this solution could be implemented in the needle. Reviewer #2: In this work the authors present a design for a self-inserting needle with potential applications in prostate biopsy/ablation. The study experimentally evaluates the ability of the needle to insert itself, quantitatively measuring the slip ratio during deployment. The study was conducted in cadaveric human prostate tissue embedded in an agar gel phantom. The paper is very well-written and clearly presents the design, evaluation study, and results. The reviewer has a few comments and suggestions for improvement. In no particular order: There have also been recent works in other types of needles that are pulled from their tip rather than pushed from their base. For instance, [1] leverages magnetic force to pull the needle, and recently [2] leverages a screw-tip mechanism to pull the needle and magnetic torque to steer the needle. The authors may consider mentioning designs such as these which, while significantly different, may exhibit similar benefits as the proposed design: [1] M. Ilami, R. J. Ahmed, A. Petras, B. Beigzadeh, and H. Marvi, “Magnetic Needle Steering in Soft Phantom Tissue”, Scientific Reports, 10(1), pp. 1-11, 2020. [2] T. J. Schwehr, A. J. Sperry, J. D. Rolston, M. D. Alexander, J. J. Abbott, and A. Kuntz, "Toward Targeted Therapy in the Brain by Leveraging Screw-Tip Soft Magnetically Steerable Needles", Hamlyn Symposium on Medical Robotics, pp. 81-82, 2022. R2. Thank you for your compliments and for pointing out these references. In Section 1.2 (Lines 59-65), we have now added the designs and their working mechanisms to steer and overcome buckling as described by Ilami et al. (2020) and Schwehr et al. (2022). In Equation 2, d_m and d_e are used, however when describing the equation, the authors define d_t (line 280). This discrepancy should be resolved. R3. Thank you for pointing out this discrepancy. In Equation 2 and in the text, we have now changed d_t to d_e. Do the authors have any intuition regarding the differences between the agar used in the study to surround the ex vivo prostate tissue and the tissue in the human body that would represent intermediate tissue the needle must move through en route to the prostate? It may be worth briefly discussing this point and its implications for the study/results. E.g., is it possible the agar may have exaggerated the slip in this case compared with human tissue? R4. Thank you for this suggestion. In the second paragraph of Subsection 4.3, we have now added an explanation of how the agar could have increased the slip ratio because of the high stiffness of the agar (2.5wt%) used in our experiment. Moreover, we added a third paragraph, where we discuss the foreseen challenges in moving towards in vivo testing (see also R1). In this new paragraph, we discuss the effects of more and multi-layered tissue between the insertion point of the needle in in vivo conditions (i.e., the perineum) and the target point inside the prostate. Other non-MRI-ready self-propelled needles have been shown to be able to self-propel in multi-layered tissue-mimicking phantoms [3]. Moreover, as the needle is inserted further into the tissue, the role of the cutting force on the single advanced segment becomes less pertinent, which in theory would aid the self-propelling motion of the needle. [3] Scali M, Breedveld P, Dodou D. Experimental evaluation of a self-propelling bio-inspired needle in single-and multi-layered phantoms. Scientific reports. 2019;9(1):1-13. doi: 10.1038/s41598-019-56403-0 How does the shrinking tube that keeps the individual needle segments together near the tip impact the working principle of the self-propelled insertion? Does the shrinking tube hinder the insertion of the needle? If it affects this, to what expected degree? It may be worth discussing this point as well. R5. Thank you for this suggestion. We agree that an explanation of how the shrinking tube hinders the insertion mechanism of the needle is highly relevant. In Subsection 4.2, we added an explanation about how the needle’s self-propelling motion might be hindered by the increased friction force of the needle segment that is glued to the shrinking tube advances and how this effect declines as the needle further self-propels into the tissue. Can the authors quantify the degree to which the needles diverged at their tips during the experiments? Doing so would add significant context to the observation. R6. Thank you for this suggestion. Unfortunately, the resolution of the MRI system used was not high enough to quantify the degree to which the needle tips diverged. We added this explanation in Subsection 4.1. Furthermore, in Subsection 4.2, we added a future design aim where we describe that we want to point all bevel-shaped tips toward the centre of the needle tip by restricting the rotation of the needle segment tips to prevent diverging of the needle segments. In lines 395-396 in the discussion section, the authors state “This makes pneumatic actuators more suited for a discrete, stepwise motion instead of a continuous motion by using our selector mechanism, for example.” This is unclear. Are the authors stating that their mechanism is an example of a continuous motion that does not suit itself to pneumatic actuators or are they instead stating the proposed mechanism is an example of a discrete motion? The text is ambiguous. However, it is my impression that the proposed needle would be an example that can well be actuated by stepwise pneumatic mechanisms. R7. Thank you for pointing out this ambiguity. In Subsection 4.3, we now describe that a stepwise pneumatic actuation mechanism can replace the current stepwise manual translation. The authors mention the concern of heating of the nitinol in the MRI. It seems to me, however, that nitinol is not necessary as the material for the needle bundle. If the design could instead, theoretically, incorporate non-magnetic materials in the needle bundle, it may be worth mentioning this in the future work section when bringing up the heating concern. R8. We completely agree that the needle segments in the design could be replaced by needle segments of non-magnetic materials. In Subsection 4.3, we added the design consideration of changing the needle segment materials. It may be an artifact of the review process, or fixed later in the editorial process, but it is worth noting that many of the figures exhibit quite low resolution. R9. We checked the resolution of the figures during the submission process of the revision. A few typos noted: Line 109 prostat…e Line 214 or visualization R10. We removed these typos. The paper is clearly presented and quite well written. If the above comments were addressed the paper would be further strengthened. Thank you your useful suggestions. We look forward to your reaction. With kind regards, Jette Bloemberg and co-authors Submitted filename: Response to Reviewers.docx Click here for additional data file. 22 Aug 2022 Design and evaluation of an MRI-ready, self-propelled needle for prostate interventions PONE-D-22-12859R1 Dear Dr. Bloemberg, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Tommaso Ranzani, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: The authors have sufficiently addressed my prior comments and the paper is now ready for publication in my estimation. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No ********** 29 Aug 2022 PONE-D-22-12859R1 Design and evaluation of an MRI-ready, self-propelled needle for prostate interventions Dear Dr. Bloemberg: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Tommaso Ranzani Academic Editor PLOS ONE
  35 in total

1.  Heating around intravascular guidewires by resonating RF waves.

Authors:  M K Konings; L W Bartels; H F Smits; C J Bakker
Journal:  J Magn Reson Imaging       Date:  2000-07       Impact factor: 4.813

2.  Insertion experiments of a biologically inspired microtextured and multi-part probe based on reciprocal motion.

Authors:  T Parittotokkaporn; L Frasson; A Schneider; B L Davies; P Degenaar; F Rodriguez Y Baena
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2010

3.  Magnetic resonance guided, focal laser induced interstitial thermal therapy in a canine prostate model.

Authors:  R Jason Stafford; Anil Shetty; Andrew M Elliott; Sherry A Klumpp; Roger J McNichols; Ashok Gowda; John D Hazle; John F Ward
Journal:  J Urol       Date:  2010-08-19       Impact factor: 7.450

Review 4.  Buckling prevention strategies in nature as inspiration for improving percutaneous instruments: a review.

Authors:  Aimée Sakes; Dimitra Dodou; Paul Breedveld
Journal:  Bioinspir Biomim       Date:  2016-02-18       Impact factor: 2.956

5.  Experimental evaluation of a novel steerable probe with a programmable bevel tip inspired by nature.

Authors:  Luca Frasson; Francesco Ferroni; Seong Young Ko; Gorkem Dogangil; Ferdinando Rodriguez Y Baena
Journal:  J Robot Surg       Date:  2011-06-03

6.  MR imaging-guided focal laser ablation for prostate cancer: phase I trial.

Authors:  Aytekin Oto; Ila Sethi; Gregory Karczmar; Roger McNichols; Marko K Ivancevic; Walter M Stadler; Sydeaka Watson; Scott Eggener
Journal:  Radiology       Date:  2013-02-25       Impact factor: 11.105

7.  Ultrasound guided transrectal core biopsies of the palpably abnormal prostate.

Authors:  K K Hodge; J E McNeal; T A Stamey
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450

Review 8.  Ablation energies for focal treatment of prostate cancer.

Authors:  Olivia Lodeizen; Martijn de Bruin; Scott Eggener; Sébastien Crouzet; Sangeet Ghai; Ioannis Varkarakis; Aaron Katz; Jose Luis Dominguez-Escrig; Sascha Pahernik; Theo de Reijke; Jean de la Rosette
Journal:  World J Urol       Date:  2018-06-25       Impact factor: 4.226

9.  Are titanium implants actually safe for magnetic resonance imaging examinations?

Authors:  Yong-Ha Kim; Manki Choi; Jae-Won Kim
Journal:  Arch Plast Surg       Date:  2019-01-15

10.  Experimental evaluation of a self-propelling bio-inspired needle in single- and multi-layered phantoms.

Authors:  M Scali; P Breedveld; D Dodou
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.